Answers are grounded in this paper and cite their sources.
Molecular study reveals distinct quality control pathways targeting variant snRNAs in human cells, highlighting how surveillance failure disrupts RNA splicing and drives disease.
A new study by Ma and colleagues (doi:10.1101/gad.353690.126) identifies distinct quality control systems that degrade snRNA variants. Variants expressed from snRNA pseudogenes, deficient in 3′ end processing or RNP assembly, are degraded by the nuclear RNA exosome or by cytoplasmic decay initiated by TUT4/7 enzymes. When variant snRNAs are stabilized, they can assemble into spliceosomes and alter splicing. Moreover, pathogenic mutations in canonical snRNA genes can trigger aberrant degradation by these quality control mechanisms, which may contribute to disease pathology. In summary, this work reveals how cells maintain a functional pool of snRNP complexes and links their dysregulation to human diseases.
No takes yet. Share an insight, caveat, or question.
Mohan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: